Robert Y.S. Cheng and Yan Shang contributed equally to this work.
Asthma is a chronic airway disorder characterized by recurrent attacks of breathlessness and wheezing, affecting 300 million people around the world (available at:
Epigenetics provides a promising approach for understanding complex diseases like asthma. The epigenetic disruption of gene expression is now known to play an equally important role as genetic predispositions (such as polymorphism, mutation, deletion, and insertion) in the development of disease [
Recent evidence has shown that epigenetic modifications via DNA methylation can provide a possible mechanistic explanation for the link between exposure to environmental pollutants and asthma [
All experimental protocols conducted on mice were performed in accordance with the standards established by the US Animal Welfare Acts, as set forth in National Institutes of Health (NIH) guideline and the Policy and Procedures Manual of the Johns Hopkins University Animal Care and Use Committee. C57BL/6J male mice, 6 weeks old, were obtained from Jackson Laboratory (Bar Harbor, ME). Mice were first sensitized with 100 μg HDM (D. pteronyssinus) extract (Greer Laboratories, Lenoir, NC), or saline (as control) intraperitoneally (i.p.) on day 1. Starting from day 14, mice were challenged with 100 μg HDM or saline intratracheally (i.t.) three times a week for a total of 5 weeks. Two days after the last challenge six saline-exposed mice and six HDM-exposed mice were subjected to airway responsiveness measurement and sample collection (bronchoalveolar lavage (BAL), serum and lung tissues). Another set of four mice from each treatment group were harvested for isolation of ASM cells from the lung trachea.
Lung tracheas from saline- or HDM-exposed mice were collected as previously described [
Two days after the last challenge with HDM, mice were anesthetized, paralyzed, and then ventilated with a Flexivent as described [
BAL cells were washed once in saline and counted using a hemocytometer (Paul Marienfeld, LaudaKoenigshofen). Differential cell counts were obtained under light microscope after staining with Diff-Quick stain (Dade Behring, Deerfield, IL).
The protein levels of IL-4, IL-5, IgE, and Ifng were measured in serum using enzyme-linked immunosorbent assay (ELISA) kits obtained from eBiosciences (San Diego, CA).
The left lung was inflated to lung capacity with warmed agarose, cooled, and immersed in 10% normal buffered formalin before being embedded in paraffin. Paraffin-embedded sections were stained with hematoxylin and eosin (H&E) for the assessment of peribronchial inflammation. Presence of goblet cells in the epithelium of the bronchus was demonstrated by staining the paraffin-embedded section with periodic acid-Schiff (PAS). Subepithelial fibrosis and deposition of collagen was assessed by Masson’s trichrome staining on sections. Increased ASM layer was assessed by immunohistochemistry (IHC) staining of alpha-smooth muscle actin (Sma) (Santa Cruz Biotechnology, Dallas, TX).
Two hundred nanograms of genomic DNA from mouse lung tissues or isolated MASMCs was used to measure the level of 5-methylcytosine (5-mC) and 5-hydroxymethylcytosine (5-hmC) in DNA by ELISA kits (Zymo Research, Irvine, CA).
Immunoprecipitated DNA was prepared from both saline and HDM-exposed lung tissues. Sample DNA concentrations were quantified with the Quanti-iTM Picogreen dsDNA assay kit (Invitrogen, CA). A second quality check was done on Agilent 2100 HS DNA chip after DNAs were fragmented. 1 lg of DNA from each sample was fragmented on Covaris S2 and had an average length of 200 bp. Methylated DNA was captured using the MethylCap kit (Diagenode, NJ) and DNA was eluted from the protein complex. Two hundred fifty nanograms fragmented DNAs were amplified, ligated with linkers, and subjected to flow cells using the HiSeq2000 platform according to the manufacturer’s NGS protocol (Illumina, CA). About 20 million reads obtained by a single-run of massive parallel sequencing with 51 bp paired-end reads were found. Bioinformatics analysis on the raw NGS data was performed with use of CLC Genomic Workbench 6.0.3 (CLC Bios, MA) and followed manufacturer’s standard data import protocol. Reads (peaks) were mapped to the Mouse Reference Genome Build NCBI38/mm10. Significant peaks by threshold profiles at a height equivalent to an estimated false discovery rate (FDR) ≥0.001 were identified. Differentially methylated regions between HDM-exposed and saline-exposed mice were annotated to their chromosomal loci and Gene Ontology (GO) categories. To better understand the biological meaning behind the differentially methylated genome, the list of methylated candidates was exported to the Ingenuity Pathway Analysis (IPA) (Ingenuity Systems, Redwood City, CA).
Genomic DNA (200 ng) from lung tissues or MASMCs was modified with sodium bisulfite with the EZ DNA Methylation Kit (Zymo Research, Irvine, CA) before real-time PCR. Real-time PCR was done on bisulfite-treated DNA samples using primers specific for methylated DNA. Primers were listed in
Total RNA (1 μg) was isolated from lung tissues and MASMCs and reverse transcribed with iScript Reverse Transcriptase (BIO-RAD, Hercules, CA). mRNA levels of the genes were quantified by TaqMan-based or SYBR Green-based real-time PCR. Primers were listed in
Data on airway responsiveness, cell counts, cytokines levels, relative gene expression, and methylation status were expressed as the mean- ± standard deviation (SD) with six mice per treatment group (saline-exposed or HDM-exposed). The Spearman’s rank correlation coefficient (ρ) was calculated to measure the strength of the relationship between the percent of methylation of a gene’s promoter and its transcript expression level in mouse lung tissues. Ninety-five percent confidence intervals and two-tailed
HDM-exposed mice showed increases in airway reactivity and inflammation together with structural remodeling of the airways consistent with that found in other studies [
We sought to determine whether HDM-induced AHR is associated with epigenetic alterations via DNA methylation in the mouse lung. Previously, we identified global and gene-specific methylation in lung tissues and isolated ASM cells from mice with acute HDM exposure [
The most “connected” network was identified around the
In addition, we determined if repeated exposures to HDM induced changes in the mRNA expression of genes encoding proteins involved in regulating cytosine DNA methylation/hydroxmethylation/demethylation and chromatin remodeling: DNA methyltransferases (
We examined whether the global DNA methylation patterns and/or the gene–specific methylation of genes involved in Tgfb signaling are aberrantly altered in MASMCs as a result of HDM exposures. First, we observed increases in 5-hmC levels in DNA from the tracheal MASMCs isolated from HDM-exposed mice compared to those of saline-exposed mice (
In urban areas, HDM is one of the most common allergens. It has been postulated that chronic exposure to HDM extracts induces airway remodeling and AHR via immune mechanisms. For example, HDM extracts can stimulate dendritic cells to secret Il6 and induce T-helper cell (Th)2 and Th17 differentiation, which contribute to AHR [
A number of studies show epigenetic modulation of B cell and Th2 phenotypes in both allergic and non-allergic asthma [
There are sets of functional components that modulate the epigenetic information embedded in the chromatin of gene promoters in response to environmental stimuli. Down-regulation of
Advanced epigenetic technology, bioinformatics support, and proper validation assays will likely increase our ability to reveal markers for the prevention, diagnosis, and prognosis of asthma. Herein, we demonstrated the epigenetic changes associated with allergic AHR in an environmentally and clinically relevant experimental asthma model in a step-by-step manner. We first utilized a high-throughput and unbiased DNA methylation profiling approach to explore the genome-wide methylation changes in mouse lungs in response to the environmental allergen, HDM. Next, we chose two commercially available databases (CLC Genomic Workbench and IPA) to analyze the raw NGS data and map out biological networks that can be validated in subsequent studies. Then, we validated the gene expression and promoter methylation of 19 genes from the top “connected” network determined by IPA (Tgfb signaling pathway) by RTPCR and quantitative MSPCR respectively. The primers used in the MSPCR are designed to target the specific CpG sites showing the highest peak signal from NGS data for the potential candidate genes determined from the MeDIP-seq data. Furthermore, we correlated the gene expression levels of the candidate genes with their methylation status (ρ value) in order to associate DNA methylation changes with gene expression changes in the lungs from mice with allergic AHR (
In the present study, we utilized lung tissues for the methylome analysis in order to get a sufficient amount of genomic DNA for MeDIP-seq. However, we do acknowledge the heterogeneity of cells (including MASMCs, airway epithelial cells, fibroblasts, goblet cells and immune cells) in the lung tissues may have influenced our results. Epigenetic changes induced by HDM exposure in the lung or airway may involve gene dysregulation in all or a subset of these cell types. We validated the gene expression and promoter methylation status of potential MeDIP-seq candidates in both lung tissues and MASMCs cells. We examined the epigenetic changes in MASMCs for test of concept because ASM is one of the key components in AHR. We clearly demonstrated that many of the candidate genes identified using the lung tissue also undergo DNA methylation and expression changes in MASMCs from exposed mice, suggesting that the methylation changes demonstrated are occurring in a relevant cell type to AHR. However, further validation of methylation status in different cell types from the mouse lung is recommended allowing for an even clearer understanding of the pathogenesis of asthma. Future experiments like gene knock-in or knock-out assays in mouse lung are needed to demonstrate the underlying mechanisms of how epigenetic changes of potential candidates alter ASM functions and AHR. Herein, we presented differentially methylated genes, which are highly enriched in the Tgfb signaling pathway, in HDM-exposed lung and MASMCs as compared to that of saline-control. A better understanding of the regulation of Tgfb signaling in transcription would provide more specific targets for therapeutic intervention of asthma [
The authors acknowledge Jessica Hopkins and Melanie Nembald for sample preparation.
Grant sponsor: NIEHS; Grant number: ES016887 (to W.-Y.T.) and P30ES03819-EHS.
Grant sponsor: NHLBI; Grant number: HL10342 (to W.M.)
Grant sponsor: National Natural Science Foundation of China; Grant number: 81000006 (to Y.S.).
Drs. Cheng, Shang, Mitzner, and Tang designed the study. Dr. Das, Mr. Limjunyawong, and Mr. Rabold performed the lung physiological study. Dr. Shang and Ms. Dao performed the gene expression and methylation study with advice of Dr. Tang. Drs. Cheng and Tang analyzed and interpreted the results. Drs. Cheng, Sham, Mitzner, and Tang prepared the article. All authors reviewed and approved the manuscript prior submission.
Additional Supporting Information may be found in the online version of this article.
Increased airway responsiveness in HDM-exposed mice. Upper panel: schematic picture depicting the HDM sensitization and challenges used in this study. Lower panel: Methacholine (MCh) was administered to the animals at increasing doses (0.1, 0.3, 1, 3, 10, and 30 mg/mL) by a 10 s aerosol inhalation. AHR was assessed as the change in pulmonary resistance (R, cm H2O/mL/s) compared to baseline after the challenge to MCh. Circle: saline-exposed mice; square: HDM-exposed mice. Results were expressed as mean values ± SD, with six mice per treatment group (saline-exposed or HDM-exposed). Technical triplicates were performed in each measurement. *
Increased airway inflammation and remodeling in HDM-exposed mice. The lung sections were stained with (
HDM-exposed mice demonstrated decreased 5-mC and increased 5-hmC content in DNA from lungs; 5-mC and 5-hmC levels in lung DNA were detected using capture and detection antibodies followed by colorimetric quantification. Black bar: saline-exposed mice; gray bar: HDM-exposed mice.
Ingenuity pathway analysis (IPA) revealed TGF-beta signaling as the top “connected” network of differentially methylated candidates in HDM-exposed group. Candidates identified from MeDIP-seq are capitalized and in bold. The shapes of candidates in a picture represent the classifications of gene functions. PLCL2, P4HA2, PDE10A, and GAL3ST1 are classified as Enzymes. TGFB2, BMP2a, and IL36B are classified as Cytokine/Growth Factors. TRPM2 are Ion Channels. PRKG2 is a Kinase. CREBZF, SMAD2, and SKI are classified as Transcription Regulator. MSR1 and IL6R belong to Transmembrane Receptor. SLC25A12 belongs to Transporter. UNC93B1, FAM198B and CARTPT are classified as unknown functions. Solid line: direct interaction; broken line: indirect interaction. Candidates indicated by red circle were found to be significantly methylated and expressed (*
HDM-exposed mice had increased 5-hmC in DNA from mouse airway smooth muscle cells (MASMCs). (
| Type of immune cells | No. cells (1 × 104) | SD | ||
|---|---|---|---|---|
| Total | Saline | 9.22 | 2.95 | <0.01 |
| HDM | 182.29 | 63.51 | ||
| Macrophages | Saline | 9.22 | 2.94 | <0.01 |
| HDM | 30.47 | 8.98 | ||
| Neutrophils | Saline | 0 | 0 | 0.13 |
| HDM | 1.71 | 3.24 | ||
| Lymphocytes | Saline | 0.11 | 0.33 | <0.01 |
| HDM | 21.91 | 3.20 | ||
| Eosinophils | Saline | 0.01 | 0.04 | <0.01 |
| HDM | 128.06 | 64.83 | ||
|
| ||||
| Inflammatory response | Protein levels in serum | SD | ||
|
| ||||
| IL-4 | Saline | 33.93 | 23.58 | <0.01 |
| HDM | 165.24 | 85.05 | ||
| IL-5 | Saline | 140.22 | 19.28 | <0.01 |
| HDM | 192.72 | 30.34 | ||
| Ifnγ | Saline | 379.38 | 223.31 | 0.10 |
| HDM | 623.13 | 326.08 | ||
| IgE | Saline | 133.75 | 30.33 | <0.01 |
| HDM | 650.63 | 354.65 | ||
Differential cell counts from BAL were obtained under light microscope after staining with Diff-Quick stain.
Results were expressed as mean values ± standard deviation (SD), with six mice per treatment group. Technical triplicates were performed in each assay.
Protein levels of IL-4, IL-5, Ifnγ, and IgE (pg/mL) in serum were determined by ELISA.
| mRNA level (RER) in lung | SD | |||
|---|---|---|---|---|
| Smooth muscle mass | ||||
| α-Smooth muscle actin ( | Saline | 1.90 | 0.63 | 0.03 |
| HDM | 10.28 | 5.86 | ||
| Tropomyosin ( | Saline | 1.56 | 0.58 | 0.32 |
| HDM | 2.54 | 1.72 | ||
| Cell proliferation | ||||
| Cyclin D1 ( | Saline | 1.92 | 0.72 | 0.90 |
| HDM | 1.89 | 0.75 | ||
| Proliferation cell nuclear antigen ( | Saline | 1.20 | 0.17 | 0.02 |
| HDM | 2.13 | 0.51 | ||
| Smooth muscle contraction | ||||
| Camodulin kinase II delta ( | Saline | 0.88 | 0.13 | 0.03 |
| HDM | 2.19 | 0.95 | ||
| Myosin light chain kinase ( | Saline | 0.89 | 0.23 | 0.76 |
| HDM | 0.99 | 0.50 |
mRNA levels of samples were determined by RTPCR and normalized to
Results were expressed as mean values ± standard deviation (SD), with six mice per treatment group. Technical triplicates were used in the assay
| Gene | Promoter methylation (%, SD) | mRNA levels (RER, SD) | ρ, | ||||
|---|---|---|---|---|---|---|---|
| Saline | HDM | Saline | HDM | ||||
| 85.15, 4.00 | 34.06, 5.84 | <0.01 | 1.02, 0.25 | 1.99, 0.51 | 0.01 | −0.84, <0.01 | |
| 67.83, 4.46 | 10.61, 3.46 | <0.01 | 0.75, 0.20 | 1.94, 0.21 | 0.01 | −0.76, <0.01 | |
| 90.50, 2.92 | 35.55, 11.00 | 0.01 | 3.53, 2.12 | 27.02, 12.11 | 0.05 | −0.81, 0.06 | |
| 62.29, 2.49 | 24.97,4.10 | 0.01 | 1.30, 0.43 | 3.11, 1.15 | 0.02 | −0.84, <0.01 | |
| 54.09, 6.52 | 5.52, 4.04 | 0.01 | 1.96, 0.88 | 4.46, 0.68 | 0.01 | −0.77, <0.01 | |
| 78.95, 4.13 | 23.02, 2.10 | 0.01 | 3.07, 1.48 | 23.74, 6.35 | 0.04 | −0.69, 0.01 | |
| 90.71, 2.83 | 16.47, 4.21 | 0.01 | 4.05, 2.94 | 14.84, 5.18 | 0.02 | −0.78, <0.01 | |
| 91.31, 8.63 | 66.74, 4.31 | 0.01 | 0.74, 0.10 | 1.12, 0.28 | 0.04 | −0.86, <0.01 | |
| 21.24, 1.16 | 66.74, 4.31 | 0.01 | 1.29, 0.29 | 1.00, 0.09 | 0.05 | −0.31, 0.27 | |
| 65.40, 2.61 | 95.23, 3.90 | 0.01 | 0.76, 0.15 | 0.43, 0.21 | 0.04 | −0.38, 0.19 | |
Percent of gene promoter methylation from lung tissue samples of saline- or HDM-exposed mice was assayed by quantitative MSPCR. Results were expressed as mean values ± standard deviation (SD), with six mice per treatment group. Technical triplicates were used in the assay.
mRNA levels of samples were determined by RTPCR and normalized to
The Spearman’s rank correlation coefficient (ρ) was calculated to measure the strength of the relationship between the percent of methylation of a gene’s promoter and its transcript expression level in mouse lung tissues (saline- and HDM-exposed mice). Negative sign indicated inverse relationship between % promoter methylation and RER. The larger the negative value meant greater negative correlation and statistical significance was determined by a two-tailed test with
| Gene | mRNA levels (RER, SD) | ||
|---|---|---|---|
| Saline | HDM | ||
| 1.28, 0.17 | 1.37, 0.09 | 0.10 | |
| 1.35, 0.51 | 0.96, 0.42 | 0.03 | |
| 1.52, 0.25 | 1.54, 0.36 | 0.15 | |
| 1.09, 0.41 | 1.39, 0.48 | 0.41 | |
| 1.06, 0.12 | 0.87, 0.13 | 0.03 | |
| 1.32, 0.34 | 0.92, 0.22 | 0.03 | |
| 1.24, 0.31 | 1.57, 0.35 | 0.27 | |
| 1.35, 0.31 | 1.34, 0.28 | 0.32 | |
| 1.10, 0.23 | 2.25, 0.46 | 0.01 | |
| 1.05, 0.21 | 1.39, 0.21 | 0.36 | |
| 0.61, 0.34 | 0.63, 0.49 | 0.94 | |
| 0.78, 0.18 | 14.37, 11.86 | 0.05 | |
| 8.35, 7.67 | 48.75, 16.64 | 0.02 | |
| 0.73, 0.27 | 0.76, 0.20 | 0.81 | |
mRNA levels of samples were determined by RTPCR and normalized to Rpl19 transcript in the same sample. The relative level of gene transcript in saline-exposed control samples was arbitrarily assigned a value of 1.0. The relative level of gene transcript [relative expression ratio, RER] of HDM-exposed mice was normalized to the mean value of the saline group. Results were expressed as mean values ± standard deviation (SD), with six mice per treatment group. Technical triplicates were used in the assay.
Promoter Methylation and Gene Expression in Mouse Airway Smooth Muscle Cells (MASMCs)
| Gene | Promoter methylation (%, SD) | mRNA level (RER, SD) | ρ, | ||||
|---|---|---|---|---|---|---|---|
| Saline-MASMCs | HDM-MASMCs | Saline-MASMcs | HDM-MASMCs | ||||
| 88.09, 7.49 | 29.14, 2.33 | <0.01 | 0.85, 0.15 | 1.49, 0.23 | 0.02 | −0.80, <0.01 | |
| 43.70, 4.80 | 19.60, 6.71 | <0.01 | 0.85, 0.15 | 1.78, 0.07 | 0.01 | −0.74, 0.01 | |
| 41.19, 2.95 | 11.16,4.32 | <0.01 | 0.97, 0.03 | 3.96, 0.01 | 0.01 | −0.83, <0.01 | |
| 56.16, 22.31 | 15.64, 6.68 | <0.01 | 0.85, 0.15 | 3.79, 0.32 | 0.02 | −0.79, <0.01 | |
| 77.25, 7.49 | 19.68, 5.29 | <0.01 | 0.82, 0.18 | 2.94, 1.47 | 0.01 | −0.72, 0.01 | |
| 5.56, 5.23 | 10.45, 2.83 | 0.07 | 0.71, 0.29 | 1.278, 0.09 | 0.06 | −0.38, 0.22 | |
| 7.75, 2.25 | 6.53, 2.45 | 0.39 | 1.30, 0.30 | 2.74, 1.03 | 0.02 | −0.38, 0.20 | |
| 6.01, 3.74 | 10.79, 4.21 | 0.06 | 0.69, 0.02 | 1.73, 0.36 | 0.44 | 0.69, 0.02 | |
| 24.79, 9.64 | 76.62, 12.41 | <0.01 | 0.82, 0.18 | 0.41, 0.09 | 0.03 | −0.77, <0.01 | |
| 12.37, 6.14 | 9.33, 5.45 | 0.38 | 0.79, 0.21 | 0.03, 0.002 | 0.02 | 0.24, 0.45 | |
Airway smooth muscle cells were isolated from trachea of saline- (
Percent of promoter methylation from MASMCs isolated from saline- or HDM-exposed mice was assayed by quantitative MSPCR. Results were expressed as mean values ± standard deviation (SD), with four mice per treatment group. Technical triplicates were used in the assay.
mRNA levels of samples were determined by RTPCR and normalized to
The Spearman’s rank correlation coefficient (ρ) was calculated to measure the strength of the relationship between the percent of methylation of a gene’s promoter and its transcript expression level in MASMCs (saline- and HDM-exposed mice). Negative sign indicated inverse relationship between % promoter methylation and RER. The larger the negative value meant greater negative correlation and statistical significance was determined by a two-tailed test with